NEW YORK (GenomeWeb) – Invitae reported Tuesday after the close of the market that it generated $1.2 million in first quarter revenues, a 10-fold increase from $118,000 in Q1 2014.

Invitae's revenues beat the consensus Wall Street estimate of $1.1 million.

The company billed 2,200 reports, marking 23 percent sequential growth from the fourth quarter of 2014. Invitae went public in February, netting $116 million in total gross proceeds.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.